Oracle Corp shares surged 5% on Monday as retail investors stepped in to buy the dip following the company's worst weekly performance since September 2002. The rebound comes despite market concerns over a massive capital expenditure plan, as Wall Street analysts urged investors to look past the short-term cash flow strain. The Nasdaq gained 3.13% while the S&P 500 rose 1.90%, providing a broader tailwind for the tech sector.

The cloud giant suffered a 15% drawdown last week after reporting fiscal fourth-quarter results that beat Wall Street expectations but revealed ballooning capital spending. Oracle's revenue rose 20.6% year-over-year to $19.18 billion, while non-GAAP EPS of $2.11 topped the $1.97 consensus. However, investors recoiled from the company's guidance for fiscal 2027 capex of $90–95 billion and plans to raise roughly $40 billion in debt and equity. Fiscal 2026 capex hit $55.7 billion, above guided estimates, leading to $23.7 billion in negative free cash flow.

Analyst Support and Technical Levels

Despite the market's initial panic, sell-side analysts remain bullish. BofA analyst Tal Liani reiterated a Buy rating and a $240 price forecast, pointing to 93% growth in cloud IaaS/PaaS revenue. Goldman Sachs analyst Gabriela Borges raised her target from $228 to $239, noting that prepayments and bring-your-own-cloud deals cut net cash outlay to about $70 billion, making the funding picture better than the optics suggest.

Technically, Oracle is attempting to extend a rebound off the April swing low. At $193.22, the stock is trading 4.8% above its 50-day SMA ($184.99) and 14.1% above its 100-day SMA ($169.86). However, it remains 5.5% below the 20-day SMA ($205.24) and 5.8% below the 200-day SMA ($205.84), keeping overhead supply in focus. Key resistance sits at $200.50, while support is found at $179.00.

Oracle Corp faces an investigation by law firm SueWallSt regarding potential misleading statements by its officers and directors following its Q4 FY 2026 earnings release. The investigation centers on a gap between the headline financial results and the underlying outlook, which led to a more than 10% drop in the stock price. Investors who purchased Oracle securities and suffered losses are being encouraged to come forward.

Oracle reported "record" fourth quarter and full year 2026 earnings. However, the company announced plans to increase capital expenditure to up to $95 billion in fiscal 2027, compared with $55.66 billion in fiscal 2026. This figure exceeds analyst expectations of shy of 68 billion. Management revealed that fiscal 2027 gross margin will "step down," adding to the existing "around 5 points" reduction in margins reported for fiscal 2026.

To support the continued AI buildout, Oracle announced plans to raise another $40 billion for fiscal 2027. This fundraising effort is set against a projected revenue of only $70 billion for the full year. The investigation concerns whether Oracle made materially false or misleading statements regarding its financial performance, margin deterioration, and the need to raise further capital.

Key Financial Projections

The investigation focuses on the period surrounding the earnings release on June 10, 2026. Eligibility to participate in the investigation is based on purchase date and documented losses, rather than current share ownership. Investors who bought Oracle shares and sold at a loss may still participate.

SueWallSt, identified as a top 50 securities litigation firm, is offering free, no-obligation evaluations for affected investors. The firm handles securities investigations on a pure contingency basis, meaning there are no upfront fees or out-of-pocket costs for participants. Investors can contact Joseph E. Levi, Esq. via email or telephone to submit their information.